valerates has been researched along with naltrexone in 1 studies
| Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (naltrexone) | Trials (naltrexone) | Recent Studies (post-2010) (naltrexone) |
|---|---|---|---|---|---|
| 2,251 | 294 | 457 | 8,745 | 1,228 | 2,642 |
| Protein | Taxonomy | valerates (IC50) | naltrexone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0051 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0063 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.006 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0319 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0093 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0377 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0076 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooks, PA; Hamad, MO; Hammell, DC; Klausner, M; Stinchcomb, AL; Stolarczyk, EI | 1 |
1 other study(ies) available for valerates and naltrexone
| Article | Year |
|---|---|
Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent.
Topics: Algorithms; Biotransformation; Butyrates; Chromatography, High Pressure Liquid; Diffusion; Drug Stability; Humans; In Vitro Techniques; Naltrexone; Narcotic Antagonists; Prodrugs; Skin; Skin Absorption; Spectrophotometry, Ultraviolet; Valerates | 2005 |